Clinical Trial

Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated July 12, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, double-blind, double-dummy, randomized clinical trial comparing the efficacy and safety of tirofiban versus placebo in preventing recurrence of stroke for patients with intracranial artery stenosis and high-risk acute non-disabling cerebrovascular events.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-03-13; most recent amendment 2024-07-11.
Status change: Not Yet Recruiting → Recruiting 2024-07-11
Trial Details
NCT Number NCT06319846
Lead Sponsor Beijing Tiantan Hospital
Conditions Ischemic Stroke, Acute, TIA, Symptomatic Intracranial Artery Stenosis
Enrollment 4,674 participants
Start Date 2024-07-11
Primary Completion 2025-10 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-12